Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
26,213
Total Claims
$1.3M
Drug Cost
873
Beneficiaries
$1,496
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-44%
Opioid rate vs peers
2.1% vs 3.8% avg
+27%
Cost per patient vs peers
$1,496 vs $1,174 avg
+9%
Brand preference vs peers
9.6% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.1%
Opioid Rate
555
Opioid Claims
$15K
Opioid Cost
10.8%
Long-Acting Rate
Brand vs Generic
Brand: 2,508 claims · $823K
Generic: 23,494 claims · $470K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 630 | $272K |
| Rivaroxaban | 245 | $103K |
| Mirabegron | 181 | $70K |
| Empagliflozin | 85 | $32K |
| Memantine Hcl | 598 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 77 | $26K |
| Sitagliptin Phosphate | 76 | $23K |
| Fluticasone/Umeclidin/Vilanter | 33 | $22K |
| Levothyroxine Sodium | 1,203 | $16K |
| Umeclidinium Brm/Vilanterol Tr | 33 | $16K |
| Dapagliflozin Propanediol | 17 | $15K |
| Atorvastatin Calcium | 981 | $14K |
| Dulaglutide | 14 | $14K |
| Quetiapine Fumarate | 639 | $14K |
| Potassium Chloride | 647 | $13K |
Prescribing Profile
Patient Profile
84
Avg Age
73%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data